Rockefeller Capital Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$930 Hold
100
– – ﹤0.01% 4659
2026
Q2
$1.54K Hold
100
– – ﹤0.01% 4472
2026
Q1
$1.11K Hold
100
– – ﹤0.01% 4474
2025
Q4
$534 Hold
100
– – ﹤0.01% 4521
2025
Q3
$882 Buy
+100
New +$882 ﹤0.01% 4203

Other funds holding IMUX

Rockefeller Capital Management's IMUX Position: Q3 2026 in Review

Rockefeller Capital Management held its Immunic (IMUX) position steady in Q3 2026 at 100 shares worth $930. The position accounts for ﹤0.01% of the portfolio, ranked #4659.

Rockefeller Capital Management first reported a position in IMUX in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.54K in Q2 2026. 79 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • Rockefeller Capital Management held 100 shares of Immunic worth $930 as of Q3 2026.
  • Rockefeller Capital Management left its Immunic share count unchanged in Q3 2026.
  • Immunic made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4659 holding.
  • Rockefeller Capital Management first reported a position in Immunic in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Immunic position peaked at $1.54K in Q2 2026.
  • 79 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.